Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
GLP-1 / Receptor Agonists
Retatrutide
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
This product is currently out of stock and unavailable.
